Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WASH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNPO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUOXA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ADM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
THUMPD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RXRB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102723897 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD99L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF346 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABHD16A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP2B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GHSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FARSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASTN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on